ArticleNature reviews. Neurology2009
Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease.
Article in Nature reviews. Neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed.
- Experimental menopause in 3xTg-AD mice exacerbates metabolic, inflammatory, and osteologic phenotypes aligned with Alzheimer's disease pathology.Research square · 2025Article
- VasCog 2023: 20 years of research on vascular behavioural and cognitive disorders.Cerebral circulation - cognition and behavior · 2024Article
- Stratification of Microvascular Disease Severity in the Foot Using Spatial Frequency Domain Imaging.Journal of diabetes science and technology · 2023Article
- Confronting racially exclusionary practices in the acquisition and analyses of neuroimaging data.Nature neuroscience · 2023Review
- Chronic pain is a risk factor for incident Alzheimer's disease: a nationwide propensity-matched cohort using administrative data.Frontiers in aging neuroscience · 2023Article
- Lower insulin secretion is associated with hippocampal and parahippocampal gyrus atrophy in elderly patients with type 2 diabetes mellitus.Journal of diabetes investigation · 2021Article
- Diabetic Kinome Inhibitors-A New Opportunity for β-Cells Restoration.International journal of molecular sciences · 2021Review
- Upregulated expression of a subset of genes inFASEB bioAdvances · 2021Article
- Diabetes mellitus type 2 impedes functional recovery, neuroplasticity and quality of life after stroke.Journal of family medicine and primary care · 2020Article
- Interaction betweenAlzheimer's & dementia (Amsterdam, Netherlands) · 2020Article
- Differences in topological progression profile among neurodegenerative diseases from imaging data.eLife · 2019Article
- Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study.Diabetes & metabolism journal · 2019Article
- Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs.Journal of diabetes and metabolic disorders · 2019Review
- Quantitative quality-control metrics forBiomedical optics express · 2019Article
- Deep spectral learning for label-free optical imaging oximetry with uncertainty quantification.Light, science & applications · 2019Article
- Changes of myelin basic protein in the hippocampus of an animal model of type 2 diabetes.Laboratory animal research · 2018Article
- New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.Metabolic brain disease · 2018 · on this mapReview
- Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology.ACS medicinal chemistry letters · 2018Article
- Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin.Acta neuropathologica communications · 2018Article
- p66Shc Signaling Mediates Diabetes-Related Cognitive Decline.Scientific reports · 2018Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
Epidemiological studies suggest that the risk of developing cognitive impairment and dementia is increased in individuals with diabetes mellitus, although the evidence from clinicopathological studies on neurodegenerative changes is at odds with these observations. A thorough appraisal of concomitant vascular changes in dementia might resolve this incongruity.
Indexed as
Identifiers
19498432What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.